Charles Schwab Investment Management Inc Rezolute, Inc. Call Options Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RZLT
# of Institutions
33Shares Held
26.8MCall Options Held
0Put Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA10.2MShares$42.7 Million0.06% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.02MShares$12.7 Million0.5% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$11.8 Million0.95% of portfolio
-
Affinity Asset Advisors, LLC New York, NY1.6MShares$6.74 Million0.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.55MShares$6.54 Million0.0% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $163M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...